Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Clinical Severity of SARS-CoV-2 Omicron Variant Compared with Delta among Hospitalized COVID-19 Patients in Belgium during Autumn and Winter Season 2021–2022
Nina Van Goethem, Pui Yan Jenny Chung, Marjan Meurisse, et al.
Viruses (2022) Vol. 14, Iss. 6, pp. 1297-1297
Open Access | Times Cited: 63

Showing 1-25 of 63 citing articles:

Severity of Omicron (B.1.1.529) and Delta (B.1.617.2) SARS-CoV-2 infection among hospitalised adults: a prospective cohort study in Bristol, United Kingdom
Catherine Hyams, Robert Challen, Robin Marlow, et al.
The Lancet Regional Health - Europe (2022) Vol. 25, pp. 100556-100556
Open Access | Times Cited: 124
Clinical outcomes of the severe acute respiratory syndrome coronavirus 2 Omicron and Delta variant: systematic review and meta-analysis of 33 studies covering 6 037 144 coronavirus disease 2019–positive patients
Feihong Hu, Yijie Jia, Dan‐Yan Zhao, et al.
Clinical Microbiology and Infection (2023) Vol. 29, Iss. 7, pp. 835-844
Open Access | Times Cited: 56
Variability in the Clinical Course of COVID-19 in a Retrospective Analysis of a Large Real-World Database
Robert Flisiak, Piotr Rzymski, Dorota Zarębska‐Michaluk, et al.
Viruses (2023) Vol. 15, Iss. 1, pp. 149-149
Open Access | Times Cited: 38
Comparison of SARS-CoV-2 variants of concern in primary human nasal cultures demonstrates Delta as most cytopathic and Omicron as fastest replicating
Nikhila S. Tanneti, Anant K. Patel, Li Tan, et al.
mBio (2024) Vol. 15, Iss. 4
Open Access | Times Cited: 15
Vaccine effectiveness against transmission of alpha, delta and omicron SARS-COV-2-infection, Belgian contact tracing, 2021–2022
Toon Braeye, Lucy Catteau, Ruben Brondeel, et al.
Vaccine (2023) Vol. 41, Iss. 20, pp. 3292-3300
Open Access | Times Cited: 37
Outcomes of Elderly Patients Hospitalized with the SARS-CoV-2 Omicron B.1.1.529 Variant: A Systematic Review
Roxana Manuela Fericean, Cristian Oancea, Akash Reddy Reddyreddy, et al.
International Journal of Environmental Research and Public Health (2023) Vol. 20, Iss. 3, pp. 2150-2150
Open Access | Times Cited: 23
Differences between the course of SARS-CoV-2 infections in the periods of the Delta and Omicron variants dominance in Poland
Krystyna Dobrowolska, Michał Brzdęk, Dorota Zarębska‐Michaluk, et al.
Polskie Archiwum Medycyny Wewnętrznej (2023)
Open Access | Times Cited: 22
COVID-19 vaccination and BA.1 breakthrough infection induce neutralising antibodies which are less efficient against BA.4 and BA.5 Omicron variants, Israel, March to June 2022
Limor Kliker, Neta S. Zuckerman, Nofar Atari, et al.
Eurosurveillance (2022) Vol. 27, Iss. 30
Open Access | Times Cited: 32
Clinical outcomes and phylogenetic analysis in reflection with three predominant clades of SARS‐CoV‐2 variants
Kameran M. Ali, Peshnyar M.A. Rashid, Ayad M. Ali, et al.
European Journal of Clinical Investigation (2023) Vol. 53, Iss. 9
Open Access | Times Cited: 19
AVERTED MORTALITY BY COVID-19 VACCINATION IN BELGIUM BETWEEN 2021 AND 2023
Veerle Stouten, Izaak Van Evercooren, Catharina Vernemmen, et al.
medRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Tracking the genetic diversity of SARS-CoV-2 variants in Nicaragua throughout the COVID-19 pandemic
Gerald Vásquez Alemán, Cristhiam Cerpas, José G. Juárez, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Genomic Epidemiology of the Main SARS‐CoV‐2 Variants Circulating in Italy During the Omicron Era
Annalisa Bergna, Alessia Lai, Fabio Sagradi, et al.
Journal of Medical Virology (2025) Vol. 97, Iss. 2
Open Access
Surfing the Waves: Differences in Hospitalised COVID-19 Patients across 4 Variant Waves in a Belgian University Hospital
Lucie Seyler, Els Van Nedervelde, Diederik De Cock, et al.
Viruses (2023) Vol. 15, Iss. 3, pp. 618-618
Open Access | Times Cited: 14
Comparison of the clinical characteristics of SARS-CoV-2 Delta (B.1.617.2) and Omicron (B.1.1.529) infected patients from a single hospitalist service
N. Radhakrishnan, Min Liu, Bukunmi Michael Idowu, et al.
BMC Infectious Diseases (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 14
Severity of COVID-19 among Hospitalized Patients: Omicron Remains a Severe Threat for Immunocompromised Hosts
Louis Nevejan, Sien Ombelet, Lies Laenen, et al.
Viruses (2022) Vol. 14, Iss. 12, pp. 2736-2736
Open Access | Times Cited: 20
Multidimensional analysis of immune cells from COVID-19 patients identified cell subsets associated with the severity at hospital admission
Sergio Gil-Manso, Diego Herrero-Quevedo, Diego Carbonell, et al.
PLoS Pathogens (2023) Vol. 19, Iss. 6, pp. e1011432-e1011432
Open Access | Times Cited: 11
COVID-19 vaccine effectiveness against symptomatic infection and hospitalisation in Belgium, July 2021 to May 2022
Toon Braeye, Joris Adriaan Frank van Loenhout, Ruben Brondeel, et al.
Eurosurveillance (2023) Vol. 28, Iss. 26
Open Access | Times Cited: 11
SARS-CoV-2 Omicron Specific Mutations Affecting Infectivity, Fusogenicity, and Partial TMPRSS2-Independency
Romano Strobelt, Karin Broennimann, Julia Adler, et al.
Viruses (2023) Vol. 15, Iss. 5, pp. 1129-1129
Open Access | Times Cited: 10
COVID-19 Severity and Mortality in Two Pandemic Waves in Poland and Predictors of Poor Outcomes of SARS-CoV-2 Infection in Hospitalized Young Adults
Laura Ziuzia-Januszewska, Marcin Januszewski, Joanna Sosnowska-Nowak, et al.
Viruses (2022) Vol. 14, Iss. 8, pp. 1700-1700
Open Access | Times Cited: 14
Difference in the impact of coinfections and secondary infections on antibiotic use in patients hospitalized with COVID-19 between the Omicron-dominant period and the pre-Omicron period
Yasushi Murakami, Yasuhiro Nozaki, Mika Morosawa, et al.
Journal of Infection and Chemotherapy (2024) Vol. 30, Iss. 9, pp. 853-859
Open Access | Times Cited: 2
Infection kinetics, syncytia formation, and inflammatory biomarkers as predictive indicators for the pathogenicity of SARS-CoV-2 Variants of Concern in Calu-3 cells
Priyo Budi Purwono, Vimvara Vacharathit, Suwimon Manopwisedjaroen, et al.
PLoS ONE (2024) Vol. 19, Iss. 4, pp. e0301330-e0301330
Open Access | Times Cited: 2
The impact of quality-adjusted life years on evaluating COVID-19 mitigation strategies: lessons from age-specific vaccination roll-out and variants of concern in Belgium (2020-2022)
Lander Willem, Steven Abrams, Nicolas Franco, et al.
BMC Public Health (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 2
Primary SARS-CoV-2 variant of concern infections elicit broad antibody Fc-mediated effector functions and memory B cell responses
Karlijn van der Straten, Denise Guerra, Gius Kerster, et al.
PLoS Pathogens (2024) Vol. 20, Iss. 8, pp. e1012453-e1012453
Open Access | Times Cited: 2
Two Years of Genomic Surveillance in Belgium during the SARS-CoV-2 Pandemic to Attain Country-Wide Coverage and Monitor the Introduction and Spread of Emerging Variants
Lize Cuypers, Simon Dellicour, Samuel L. Hong, et al.
Viruses (2022) Vol. 14, Iss. 10, pp. 2301-2301
Open Access | Times Cited: 13
Severity of Omicron (B.1.1.529) and Delta (B.1.617.2) SARS-CoV-2 infection among hospitalised adults: a prospective cohort study in Bristol, United Kingdom
Catherine Hyams, Robert Challen, Robin Marlow, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 12
Page 1 - Next Page

Scroll to top